838 related articles for article (PubMed ID: 29675018)
1. Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy.
Albini A; Bruno A; Noonan DM; Mortara L
Front Immunol; 2018; 9():527. PubMed ID: 29675018
[TBL] [Abstract][Full Text] [Related]
2. Innate immune cells in the tumor microenvironment.
Li MO; Wolf N; Raulet DH; Akkari L; Pittet MJ; Rodriguez PC; Kaplan RN; Munitz A; Zhang Z; Cheng S; Bhardwaj N
Cancer Cell; 2021 Jun; 39(6):725-729. PubMed ID: 34129817
[TBL] [Abstract][Full Text] [Related]
3. Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression.
Bruno A; Mortara L; Baci D; Noonan DM; Albini A
Front Immunol; 2019; 10():771. PubMed ID: 31057536
[TBL] [Abstract][Full Text] [Related]
4. Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer.
Georganaki M; van Hooren L; Dimberg A
Front Immunol; 2018; 9():3081. PubMed ID: 30627131
[TBL] [Abstract][Full Text] [Related]
5. The roles of tumor-associated macrophages in tumor angiogenesis and metastasis.
Fu LQ; Du WL; Cai MH; Yao JY; Zhao YY; Mou XZ
Cell Immunol; 2020 Jul; 353():104119. PubMed ID: 32446032
[TBL] [Abstract][Full Text] [Related]
6. A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis.
Bruno A; Ferlazzo G; Albini A; Noonan DM
J Natl Cancer Inst; 2014 Aug; 106(8):dju200. PubMed ID: 25178695
[TBL] [Abstract][Full Text] [Related]
7. Mast cells and macrophages exert beneficial and detrimental effects on tumor progression and angiogenesis.
Ribatti D
Immunol Lett; 2013 May; 152(2):83-8. PubMed ID: 23685256
[TBL] [Abstract][Full Text] [Related]
8. Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy.
Bule P; Aguiar SI; Aires-Da-Silva F; Dias JNR
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575965
[TBL] [Abstract][Full Text] [Related]
9. Innate effector cells in angiogenesis and lymphangiogenesis.
Varricchi G; Loffredo S; Galdiero MR; Marone G; Cristinziano L; Granata F; Marone G
Curr Opin Immunol; 2018 Aug; 53():152-160. PubMed ID: 29778674
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy.
Tartour E; Pere H; Maillere B; Terme M; Merillon N; Taieb J; Sandoval F; Quintin-Colonna F; Lacerda K; Karadimou A; Badoual C; Tedgui A; Fridman WH; Oudard S
Cancer Metastasis Rev; 2011 Mar; 30(1):83-95. PubMed ID: 21249423
[TBL] [Abstract][Full Text] [Related]
11. Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity.
Lee WS; Yang H; Chon HJ; Kim C
Exp Mol Med; 2020 Sep; 52(9):1475-1485. PubMed ID: 32913278
[TBL] [Abstract][Full Text] [Related]
12. Mast cells as targets for immunotherapy of solid tumors.
Oldford SA; Marshall JS
Mol Immunol; 2015 Jan; 63(1):113-24. PubMed ID: 24698842
[TBL] [Abstract][Full Text] [Related]
13. ROLE OF INNATE LYMPHOID CELLS DURING CANCER.
Tashireva LA; Zavgorodskaya KO; Perelmuter VM
Tsitologiia; 2016; 58(12):901-7. PubMed ID: 30188105
[TBL] [Abstract][Full Text] [Related]
14. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.
Fukumura D; Kloepper J; Amoozgar Z; Duda DG; Jain RK
Nat Rev Clin Oncol; 2018 May; 15(5):325-340. PubMed ID: 29508855
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity.
Harrell CR; Volarevic A; Djonov VG; Jovicic N; Volarevic V
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830312
[TBL] [Abstract][Full Text] [Related]
16. The Complex Role of Neutrophils in Tumor Angiogenesis and Metastasis.
Liang W; Ferrara N
Cancer Immunol Res; 2016 Feb; 4(2):83-91. PubMed ID: 26839309
[TBL] [Abstract][Full Text] [Related]
17. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
Gaggero S; Witt K; Carlsten M; Mitra S
Front Immunol; 2020; 11():621225. PubMed ID: 33584718
[TBL] [Abstract][Full Text] [Related]
18. Activities of stromal and immune cells in HPV-related cancers.
Barros MR; de Melo CML; Barros MLCMGR; de Cássia Pereira de Lima R; de Freitas AC; Venuti A
J Exp Clin Cancer Res; 2018 Jul; 37(1):137. PubMed ID: 29976244
[TBL] [Abstract][Full Text] [Related]
19. Innate immunity in cutaneous melanoma.
Mignogna C; Scali E; Camastra C; Presta I; Zeppa P; Barni T; Donato G; Bottoni U; Di Vito A
Clin Exp Dermatol; 2017 Apr; 42(3):243-250. PubMed ID: 28052512
[TBL] [Abstract][Full Text] [Related]
20. Plasticity in Pro- and Anti-tumor Activity of Neutrophils: Shifting the Balance.
Furumaya C; Martinez-Sanz P; Bouti P; Kuijpers TW; Matlung HL
Front Immunol; 2020; 11():2100. PubMed ID: 32983165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]